Eurofins CEREP France

Eurofins Cerep SA
Le bois l'Evêque
86600
Celle-Lévescault
France

Phone: +33 (0)5 49 89 30 00
Fax: +33 (0)5 49 43 21 70

CerepClientServices@eurofins.com

www.eurofinscereppanlabs.com

Eurofins Cerep was founded in December 1989 in Poitiers, France, as a service company to provide solutions for in vitro drug profiling and drug screening in pharmacology, allowing faster and cost-effective drug discovery by identifying at early stages the most promising drug candidates, as well as eliminating those compounds likely to fail in development.

Specialties include radioligand binding assays, enzymes (kinases, epigenetics, etc.), cell-based and tissue assays.

In 1994, Eurofins Cerep launched the first catalog of assays for pharmacological drug profiling and was one of the pioneers in High Throughput Screening in 1995.

Eurofins Cerep has also developed a unique database, BioPrint®, and related IT tools compiling both literature and proprietary data for 2,500 drugs in order to better understand the relationship between in vitro effects and clinical properties of drug candidates.

Eurofins acquired Cerep in March 2013. Both entities Cerep and Panlabs have merged to form Eurofins Cerep-Panlabs.

Services:

• Soluble and membrane receptors assays (GPCR; transporters; Ion channels; Nuclear receptors; Cytokines; Other receptors)
• Enzyme assays (Kinases; Epigenetics; Other enzymes)
• Custom services (Assay development; BioPrint®)